Image

    Polycystic Ovary Syndrome and Risks for COVID-19 Infection: A Comprehensive Review

    Sebastião Freitas de Medeiros, Márcia Marly Winck Yamamoto, Matheus Antônio Souto de Medeiros … Bruna Barcelo Barbosa
    Studysummary This review reports that women with polycystic ovary syndrome are at 28%–50% higher risk of SARS-CoV-2 infection, with increased rates of COVID-19-related hospitalization, morbidity, and mortality.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 17

    1. The Immune System Response in COVID-19 Infection in Polycystic Ovary Syndrome International Journal Of Medical Science And Clinical Invention · 2021
    2. The Double-Edged Sword of Testosterone’s Role in the COVID-19 Pandemic Frontiers in Endocrinology · 2021
    3. Sex Differences in COVID-19: The Role of Androgens in Disease Severity and Progression Endocrine · 2020
    4. Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19 Journal of the European Academy of Dermatology and Venereology · 2020
    5. Polycystic Ovary Syndrome (PCOS) and COVID-19: An Overlooked Female Patient Population at Potentially Higher Risk During the COVID-19 Pandemic BMC Medicine · 2020
    6. Are Sex Discordant Outcomes in COVID-19 Related to Sex Hormones? Seminars in Oncology · 2020
    7. Androgen Sensitivity Gateway to COVID-19 Disease Severity Drug Development Research · 2020
    8. Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of COVID-19 Infection? Frontiers in Public Health · 2020
    9. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020
    10. What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy Dermatologic Therapy · 2020
    11. Polycystic Ovary Syndrome, Androgen Excess, and the Risk of Nonalcoholic Fatty Liver Disease in Women: A Longitudinal Study Based on a United Kingdom Primary Care Database PLOS Medicine · 2018
    12. Vitamin D Receptor Polymorphisms and Polycystic Ovary Syndrome: A Systematic Review Journal of Obstetrics and Gynaecology Research · 2017
    13. Ovarian Hypertension: Polycystic Ovary Syndrome Endocrinology and Metabolism Clinics of North America · 2011
    14. Polycystic Ovary Syndrome: Comprehensive Overview and Diagnostic Criteria The Lancet · 2007
    15. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006
    16. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients The Journal of Clinical Endocrinology and Metabolism · 2004
    17. The Pathophysiology of Polycystic Ovary Syndrome Clinical endocrinology · 2003

    Related research 4

    1. Current Aspects of Polycystic Ovary Syndrome: A Literature Review Revista Da Associacao Medica Brasileira · 2016
    2. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011
    3. The Diagnosis of Polycystic Ovary Syndrome in Adolescents American Journal of Obstetrics and Gynecology · 2010
    4. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004